GPT Healthcare IPO Subscription Closes: In a significant development, the initial public offering (IPO) of GPT Healthcare, a prominent regional healthcare company in Eastern India, concluded today with subscriptions reaching 8.52 times the offered shares. As the market awaits the official listing price, early indications suggest a modest premium.

GPT Healthcare IPO Subscription Closes

Reports reveal that the Grey Market Premium (GMP) for GPT Healthcare hovers around ₹9. The GMP serves as an unofficial gauge of investor sentiment, reflecting the premium at which unlisted shares trade in the grey market. With a GMP of ₹9, investors anticipate the listing price to potentially exceed the issue price band of ₹177 – ₹186 per share by ₹9.

However, market analysts caution against relying solely on the GMP, highlighting its limitations as a predictive tool. The actual listing price, to be unveiled on February 29, 2024, will be determined by market dynamics, including supply and demand forces.

Opinions among analysts remain divided regarding the prospects of GPT Healthcare’s IPO. While some acknowledge the company’s robust regional presence and favorable financial performance, others raise concerns about its relatively high valuation and potential risks such as staff attrition and lower bed occupancy rates.

Despite the divergence in views, the oversubscription of the IPO underscores investor interest in India’s healthcare sector. The final listing price on February 29th will offer a clearer insight into investor confidence in GPT Healthcare’s future trajectory and the broader healthcare landscape in the region.